Evaluating the Immunogenicity of an Intranasal Microparticle Combination Vaccine for COVID-19 and Influenza
The IN-MP combination vaccine produced immune responses comparable to or higher than the IM route, indicating its potential as an alternative to IM injections.
Authors
- Sharon Vijayanand (ORCID: https://orcid.org/0000-0002-4365-4157)
- Smital Patil (ORCID: https://orcid.org/0000-0001-5688-9644)
- Priyal Bagwe (ORCID: https://orcid.org/0000-0001-7151-5018)
- Emmanuel Adediran
- Martin J. D’Souza
- Revanth Singh
Institutions
- Mercer University (US)
- Mercer University Health Sciences Center (US)
Publication Details
- Journal
- Vaccines
- Published
- 2025-03-07
- DOI
- https://doi.org/10.3390/vaccines13030282
- Citations
- 2
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 2.79